Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy

Cancer, a group of diseases responsible for the second largest cause of global death, is considered one of the main public health problems today. Despite the advances, there are still difficulties in the development of more efficient cancer therapies and fewer adverse effects for the patients. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lôbo, Giovanna C. N. B., Paiva, Karen L. R., Silva, Ana Luísa G., Simões, Marina M., Radicchi, Marina A., Báo, Sônia N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399799/
https://www.ncbi.nlm.nih.gov/pubmed/34452128
http://dx.doi.org/10.3390/pharmaceutics13081167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399799/
https://www.ncbi.nlm.nih.gov/pubmed/34452128
http://dx.doi.org/10.3390/pharmaceutics13081167

Ejemplares similares